We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

How Researchers Are Bringing Sustainability to Scientific Discovery

Research is advancing exciting areas of science at an unprecedented pace, but the disposable materials, powered equipment and shipping associated with experiments, sample storage and transport of reagents contribute to high energy consumption and significant waste. How are researchers bringing sustainability to scientific discovery?
Industry Insight

Developing a Sustainable Source of Squalene

Technology Networks spoke to Jason Ornstein and Barry Holtz to learn how Synshark and Phylloceuticals are working together to address current challenges associated with squalene supply and access.

Industry Insight

The Spotlight on mRNA: A Conversation With Moderna

Technology Networks had the pleasure of interviewing Sunny Himansu M.B.B.S., D.SM – associate director, infectious diseases at Moderna – to discuss the biotech company's pipeline, how a collaboration with IAVI aims to make mRNA-based preventives and therapeutics globally accessible and the future of mRNA in medicine.
Industry Insight

The Bright Future of mRNA

Technology Networks interviewed Frank DeRosa, chief technology officer and head of research at the mRNA Center of Excellence, Sanofi, to discuss the “bright future” of mRNA platforms.
Industry Insight

2022: The Year We Implement COVID-19 Lessons Into Practice

As we seek a better tomorrow, here are three predictions from global life science and diagnostics company, PerkinElmer, that will lead to better health outcomes.
Industry Insight

Developing Temperature-Stable ADDomer Vaccines for Untreatable Diseases

Technology Networks spoke with Jonathan Hare, PhD, Imophoron’s Head of Immunology, to learn more about the ADDomer™ vaccine platform, the benefits of administering vaccines by a variety of administrative routes and the infectious diseases they are currently working to develop vaccines for.
Industry Insight

Developing a Vaccine for Alzheimer’s Disease

To learn more about a universal vaccine technology and how the platform could be applied to Alzheimer's disease and other neurological indications, Technology Networks spoke with Roman Kniazev, chief executive officer at Nuravax.
Industry Insight

Simulator Technology Can Predict Optimal Vaccine Dosing

Certara is developing biosimulation and tech-enabled approaches to help scientists answer key questions at various stages of the development pipeline, serving to inform and accelerate the path to regulatory approval. One such approach, the company’s Vaccine Simulator™, can be leveraged across different therapeutic areas to determine optimal vaccine dosing and dosing regimens for different patient cohorts.
Industry Insight

Developing Thermostable Vaccines To Improve Accessibility Worldwide

We spoke to Ozgur Tuncer, chief executive officer of Stablepharma to find out more about the company’s thermo-stabilization technology called StablevaX™ and how it is being used as a complementary technology for COVID-19 vaccines. He also highlights the impact “fridge-free” vaccines could have more generally.
Industry Insight

Safeguarding Viability and Efficacy of COVID-19 Vaccines: Key Considerations

Learn how a freezer inventory management software enables biobanks to seamlessly manage & track storage locations of vaccines, ensure effective cold chain management, assuring quality and safe distribution of COVID-19 vaccines.
Advertisement